Interaction of Microbubbles with Ultrasound
- 1 October 1999
- journal article
- Published by Wiley in Echocardiography
- Vol. 16 (s1) , 733-741
- https://doi.org/10.1111/j.1540-8175.1999.tb00143.x
Abstract
The clinical need for bedside myocardial perfusion studies is obvious in the present era of revascularization. Animal and first clinical studies suggest that microbubbles can be used as intravascular tracers of perfusion in conjunction with echocardiography as an imaging modality. In order to fully appreciate the potential and limitations of this approach, the complex interactions of microbubbles within an acoustic field need to be elucidated. Most importantly, there is a strong dependence of bubble effects on the acoustic pressure. At low pressures, linear backscatter yields low signal intensities; at medium range of pressures, bubble resonance causes the reflection of nonlinear signals with harmonic frequencies; and at high pressures, spontaneous acoustic emission with high signal intensity occurs as a final signal of the bubble in its process of disintegration. Thus, in order to allow sufficient replenishment of bubbles to the imaging plane, triggered imaging should be used with one frame every second to eighth cardiac cycle. Traditional gray scale echocardiography was not successful as an imaging modality because of the similarity of gray shades between the myocardium and the contrast effect. Subsequently, second harmonic imaging was developed and was fairly successful in contrast detection, although inherent problems persisted due to the overlap of fundamental and harmonic frequencies in the filtered signals. Harmonic power Doppler imaging turned out as the most sensitive acquisition method, however, with an early dropout at medium range attenuation. In theory, the new technique of pulse inversion may be most promising as this bubble specific imaging modality should combine high sensitivity of detection with great tolerance for attenuation effects in humans. First in vitro studies have confirmed its superiority over harmonic power Doppler in combination with stabilized microbubbles such as SonoVue™. Thus, we will have to accomplish a lot more work and comparative studies in humans before myocardial contrast echocardiography can emerge as a reproducible technique for evaluating myocardial perfusion with high diagnostic accuracy.Keywords
This publication has 10 references indexed in Scilit:
- Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiogramsJournal of the American College of Cardiology, 1998
- Detection of perfusion defects during coronary occlusion and myocardial reperfusion after thrombolysis by intravenous administration of the echo-enhancing agent BR1.Journal of the American Society of Echocardiography, 1998
- Second Harmonic Power Doppler Imaging Improves Myocardial Detection of the Contrast Agent BR1 - Comparison of Four Acquisition TechniquesJournal of the American College of Cardiology, 1998
- Myocardial Contrast EchocardiographyCirculation, 1997
- Doppler energy: A new acquisition technique for the transthoracic detection of myocardial perfusion defects with the use of a venous contrast agentJournal of the American Society of Echocardiography, 1997
- Stimulated Acoustic Emission: Nonbackscatter Contrast Effect of Microbubbles Seen with Harmonic Power Doppler ImagingEchocardiography, 1997
- Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injectionJournal of the American College of Cardiology, 1996
- Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albuminJournal of the American College of Cardiology, 1996
- Successful Opacification of the Left Heart Chambers on Echocardiographic Examination after Intravenous Injection of a New Saccharide Based Contrast AgentEchocardiography, 1990
- Contrast echocardiography for evaluation of myocardial perfusion: Effects of coronary angioplastyJournal of the American College of Cardiology, 1986